Dual-responsive TPGS crosslinked nanocarriers to overcome multidrug resistance
Author:
Affiliation:
1. School of Pharmacy
2. Guangdong Medical University
3. Dongguan
4. China
5. Department of Otolaryngology-Head and Neck Surgery
6. Guangdong Provincial People's Hospital
7. Guangdong Academy of Medical Sciences
8. Guangzhou 510080
Abstract
Efficient delivery of chemotherapeutic agents into tumor cells and reversal of chemoresistance are crucially important to enhance cancer therapy.
Funder
National Natural Science Foundation of China
Traditional Chinese Medicine Bureau of Guangdong Province
Publisher
Royal Society of Chemistry (RSC)
Subject
General Materials Science,Biomedical Engineering,General Chemistry,General Medicine
Link
http://pubs.rsc.org/en/content/articlepdf/2020/TB/D0TB01140A
Reference53 articles.
1. Overcoming multidrug resistance via simultaneous delivery of cytostatic drug and P-glycoprotein inhibitor to cancer cells by HPMA copolymer conjugate
2. Volume-regulated chloride channels associated with the human multidrug-resistance P-glycoprotein
3. A Transformable Chimeric Peptide for Cell Encapsulation to Overcome Multidrug Resistance
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Reduction-sensitive shell crosslinked TPGS micelles: Formulation and colloidal characterizations;Colloids and Surfaces A: Physicochemical and Engineering Aspects;2023-11
2. Artesunate carriers induced ferroptosis to overcome biological barriers for anti-cancer;European Journal of Pharmaceutics and Biopharmaceutics;2023-09
3. CPP Functionalized Nanoparticles;CPP, Cell-Penetrating Peptides;2023
4. Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer;Journal of Nanobiotechnology;2022-09-24
5. Micelles of Licorice chalcone A for oral administration: preparation, in vitro, in vivo, and hepatoprotective activity evaluation;Journal of Nanoparticle Research;2022-05-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3